Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method.

Murakami R, Hirai T, Sugahara T, Fukuoka H, Toya R, Nishimura S, Kitajima M, Okuda T, Nakamura H, Oya N, Kuratsu J, Yamashita Y.

Radiology. 2009 Jun;251(3):838-45. doi: 10.1148/radiol.2513080899. Epub 2009 Mar 24.

PMID:
19318585
2.

Minimum apparent diffusion coefficient for the differential diagnosis of ganglioglioma.

Kikuchi T, Kumabe T, Higano S, Watanabe M, Tominaga T.

Neurol Res. 2009 Dec;31(10):1102-7. doi: 10.1179/174313209X382539. Epub 2009 Jan 9.

PMID:
19138470
3.

Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.

Wang S, Kim S, Chawla S, Wolf RL, Zhang WG, O'Rourke DM, Judy KD, Melhem ER, Poptani H.

Neuroimage. 2009 Feb 1;44(3):653-60. doi: 10.1016/j.neuroimage.2008.09.027. Epub 2008 Oct 7.

4.

Preoperative grading of presumptive low-grade astrocytomas on MR imaging: diagnostic value of minimum apparent diffusion coefficient.

Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K.

AJNR Am J Neuroradiol. 2008 Nov;29(10):1872-7. doi: 10.3174/ajnr.A1254. Epub 2008 Aug 21.

5.

Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors.

Kinoshita M, Hashimoto N, Goto T, Kagawa N, Kishima H, Izumoto S, Tanaka H, Fujita N, Yoshimine T.

Neuroimage. 2008 Oct 15;43(1):29-35. doi: 10.1016/j.neuroimage.2008.06.041. Epub 2008 Jul 11.

PMID:
18672074
6.

Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging.

Toh CH, Castillo M, Wong AM, Wei KC, Wong HF, Ng SH, Wan YL.

AJNR Am J Neuroradiol. 2008 Oct;29(9):1630-5. doi: 10.3174/ajnr.A1170. Epub 2008 Jun 26.

7.

Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: analysis of fractional anisotropy and mean diffusivity.

Lee HY, Na DG, Song IC, Lee DH, Seo HS, Kim JH, Chang KH.

J Comput Assist Tomogr. 2008 Mar-Apr;32(2):298-303. doi: 10.1097/RCT.0b013e318076b44d.

PMID:
18379322
8.

Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?

Danchaivijitr N, Waldman AD, Tozer DJ, Benton CE, Brasil Caseiras G, Tofts PS, Rees JH, Jäger HR.

Radiology. 2008 Apr;247(1):170-8. doi: 10.1148/radiol.2471062089.

PMID:
18372467
9.

Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.

Law M, Young RJ, Babb JS, Peccerelli N, Chheang S, Gruber ML, Miller DC, Golfinos JG, Zagzag D, Johnson G.

Radiology. 2008 May;247(2):490-8. doi: 10.1148/radiol.2472070898. Epub 2008 Mar 18.

10.

Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging.

Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y.

Radiology. 2007 May;243(2):493-9. Epub 2007 Mar 13.

PMID:
17356177
11.

Neuropathology for the neuroradiologist: palisades and pseudopalisades.

Wippold FJ 2nd, Lämmle M, Anatelli F, Lennerz J, Perry A.

AJNR Am J Neuroradiol. 2006 Nov-Dec;27(10):2037-41. Review.

12.

Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis.

Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T, Takahashi S.

Radiology. 2006 Dec;241(3):839-46. Epub 2006 Oct 10.

PMID:
17032910
13.

Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging.

Stadlbauer A, Ganslandt O, Buslei R, Hammen T, Gruber S, Moser E, Buchfelder M, Salomonowitz E, Nimsky C.

Radiology. 2006 Sep;240(3):803-10.

PMID:
16926329
14.
15.

Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients.

Cha S.

Neuroimaging Clin N Am. 2006 Feb;16(1):137-47, ix. Review.

PMID:
16543089
16.

Low-grade and anaplastic gliomas: differences in architecture evaluated with diffusion-tensor MR imaging.

Goebell E, Paustenbach S, Vaeterlein O, Ding XQ, Heese O, Fiehler J, Kucinski T, Hagel C, Westphal M, Zeumer H.

Radiology. 2006 Apr;239(1):217-22. Epub 2006 Feb 16.

PMID:
16484348
17.

Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.

Law M, Oh S, Babb JS, Wang E, Inglese M, Zagzag D, Knopp EA, Johnson G.

Radiology. 2006 Feb;238(2):658-67. Epub 2006 Jan 5.

PMID:
16396838
18.

Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.

Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim CC.

Neurosurgery. 2005 May;56(5):919-26; discussion 919-26.

PMID:
15854239
19.

Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas.

Inoue T, Ogasawara K, Beppu T, Ogawa A, Kabasawa H.

Clin Neurol Neurosurg. 2005 Apr;107(3):174-80.

PMID:
15823671
20.

Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas?

White ML, Zhang Y, Kirby P, Ryken TC.

AJNR Am J Neuroradiol. 2005 Apr;26(4):784-90.

Items per page

Supplemental Content

Write to the Help Desk